CA2914503A1 - Trans-clomiphene and its analogues as agents that increase bone mineral density - Google Patents

Trans-clomiphene and its analogues as agents that increase bone mineral density Download PDF

Info

Publication number
CA2914503A1
CA2914503A1 CA2914503A CA2914503A CA2914503A1 CA 2914503 A1 CA2914503 A1 CA 2914503A1 CA 2914503 A CA2914503 A CA 2914503A CA 2914503 A CA2914503 A CA 2914503A CA 2914503 A1 CA2914503 A1 CA 2914503A1
Authority
CA
Canada
Prior art keywords
clomiphene
trans
subject
bone
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2914503A
Other languages
English (en)
French (fr)
Inventor
Joseph S. Podolski
Kuang Hsu
Ronald D. Wiehle
Greg FONTENOT
Jaye THOMPSON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repros Therapeutics Inc
Original Assignee
Repros Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutics Inc filed Critical Repros Therapeutics Inc
Publication of CA2914503A1 publication Critical patent/CA2914503A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2914503A 2013-06-05 2014-06-03 Trans-clomiphene and its analogues as agents that increase bone mineral density Abandoned CA2914503A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361831542P 2013-06-05 2013-06-05
US61/831,542 2013-06-05
PCT/US2014/040704 WO2014197477A1 (en) 2013-06-05 2014-06-03 Trans-clomiphene and its analogues as agents that increase bone mineral density

Publications (1)

Publication Number Publication Date
CA2914503A1 true CA2914503A1 (en) 2014-11-12

Family

ID=52008535

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2914503A Abandoned CA2914503A1 (en) 2013-06-05 2014-06-03 Trans-clomiphene and its analogues as agents that increase bone mineral density

Country Status (10)

Country Link
US (1) US9616034B2 (zh)
EP (1) EP3003487A4 (zh)
JP (1) JP6417409B2 (zh)
KR (1) KR20160016792A (zh)
CN (1) CN105473183A (zh)
AU (1) AU2014275101B2 (zh)
CA (1) CA2914503A1 (zh)
HK (1) HK1223318A1 (zh)
MX (1) MX2015016093A (zh)
WO (1) WO2014197477A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017123577A1 (en) * 2016-01-12 2017-07-20 Repros Therapeutics Inc. Trans-clomiphene and progesterone receptor antagonist combination therapy for treating hormone-dependent conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970237A (en) * 1987-03-20 1990-11-13 Yale University Use of clomiphene to increase bone mass in premenopausal women
CA2597700A1 (en) * 2005-03-22 2006-09-28 Repros Therapeutics Inc. Dosing regimes for trans-clomiphene
WO2006135915A2 (en) 2005-06-13 2006-12-21 Rigel Pharmaceuticals, Inc. Methods and compositions for treating degenerative bone disorders
CA2865234A1 (en) * 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency

Also Published As

Publication number Publication date
KR20160016792A (ko) 2016-02-15
WO2014197477A1 (en) 2014-12-11
EP3003487A1 (en) 2016-04-13
US20160128953A1 (en) 2016-05-12
AU2014275101B2 (en) 2019-10-24
US9616034B2 (en) 2017-04-11
EP3003487A4 (en) 2017-01-25
CN105473183A (zh) 2016-04-06
JP6417409B2 (ja) 2018-11-07
AU2014275101A1 (en) 2015-12-03
JP2016520657A (ja) 2016-07-14
HK1223318A1 (zh) 2017-07-28
MX2015016093A (es) 2016-03-21

Similar Documents

Publication Publication Date Title
EP2826475B1 (en) Trans-clomiphene for treating diabetes in hypogonadal men
DE69814656T2 (de) Neue verbesserte formulierung zur behandlung der osteoporose
JP5910698B2 (ja) リセドロネート組成物およびその使用方法
JP2005516928A (ja) 骨異常のためのビスホスホネート液体製剤
HRP950293A2 (en) Oral liquidalendronate formulations
JP2018123168A (ja) 癌療法における使用のためのトランス−クロミフェン
CA2212996A1 (en) Method of lessening the risk of non-vertebral bone fractures
US20080161307A1 (en) Organic Compounds
US20080261924A1 (en) Method for the treatment of bone disorders
TW201500041A (zh) 用於代謝症候群與第２型糖尿病的反式氯米芬
AU2014275101B2 (en) Trans-clomiphene and its analogues as agents that increase bone mineral density
Tatara et al. Novel and current approaches to dietary and non-dietary bone metabolism regulation
NZ203251A (en) Pharmaceutical compositions containing 1alpha,25,26-trihydroxycholecalciferol
US20130022645A1 (en) Pharmaceutical formulations of bisphosphonate with enhanced oral bioavailability
AU2008314538B2 (en) Trans-clomiphene for metabolic syndrome
WO2002056873A2 (en) 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues
JP2002370981A (ja) 脳卒中再発防止剤

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190530

FZDE Discontinued

Effective date: 20211013